Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 90.50
0.00 (0.00%)
Aug 19, 2026, 9:25 AM CST
Acer Medical Revenue
In the year 2025, Acer Medical had annual revenue of 60.05M TWD with 19.73% growth. Acer Medical had revenue of 29.93M in the half year ending December 31, 2025, with 48.68% growth.
Revenue
60.05M
Revenue Growth
+19.73%
P/S Ratio
19.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.05M | 9.90M | 19.73% |
| Dec 31, 2024 | 50.16M | 22.71M | 82.73% |
| Dec 31, 2023 | 27.45M | 14.39M | 110.17% |
| Dec 31, 2022 | 13.06M | 3.43M | 35.66% |
| Dec 31, 2021 | 9.63M | 8.61M | 849.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| AViTA | 972.61M |
| Bioptik Technology Incorporation | 912.86M |
| Ttbio | 398.88M |
| GenMont Biotech Incorporation | 382.11M |
| TaiRx | 29.44M |
| Caliway Biopharmaceuticals | 29.39M |
| Pell Bio-Med Technology | 28.93M |
Acer Medical News
- 6 days ago - Acer Medical Quarterly report: H1 2026 - Filings
- 5 months ago - Acer Medical Quarterly report: H2 2025 - Filings